The latest Drug Administration Law amendments introduce welcome changes such as relaxed permit requirements and free prices. Pharmaceutical companies should keep abreast of the drug pricing reform, and track review and approval changes in the pipeline
China's efforts to crack down on misleading, fraudulent claims forces an industry rethink as they overturn the effects of years of aggressive marketing. The new law regulates content, target audiences and specific industries like tobacco and healthcare, and will increase compliance costs for consumer-oriented businesses
Increased transparency in government procurement.
Foreign investment catalogue revised to allow more foreign shareholding.
Pharmaceutical manufacturers and distributors no longer need a pharmaceutical licence before getting a business licence.
Foreign investment catalogue revised to allow more foreign shareholding.
Under the SAIC's new rules, business operators are now responsible for compensating consumers for faulty products sold by third party sellers. Operators should have strict measures in place to avoid losses through these reimbursement claims
Mall, market and platform business operators may be liable for advance payment of compensation to consumers.
SPC sets forth criteria for instituting public interest cases.
E-commerce WOFEs allowed in Shanghai FTZ.